Catalog No.:AA01X9EF

1801841-62-2 | 2-chloro-3-fluoro-5-iodopyridin-4-amine

Name: Name:2-chloro-3-fluoro-5-iodopyridin-4-amine
Brand: AABLOCKS
SKU: AA01X9EF
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

100mg

98%

in stock

$22.00 $15.00

- +

250mg

98%

in stock

$28.00 $20.00

- +

98%

in stock

$64.00 $45.00

- +

95%

in stock

$300.00 $210.00

- +

10g

95%

in stock

$360.00 $252.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA01X9EF

Chemical Name:

2-chloro-3-fluoro-5-iodopyridin-4-amine

CAS Number:

1801841-62-2

Molecular Formula:

C5H3ClFIN2

Molecular Weight:

272.4466

MDL Number:

MFCD31672865

SMILES:

Ic1cnc(c(c1N)F)Cl

Properties

Downstream Synthesis Route

1354223-71-4

1801841-62-2

[1]CurrentPatentAssignee:GALAPAGOSNV-WO2017/12647,2017,A1

[2]CurrentPatentAssignee:PFIZERINC-WO2020/146613,2020,A1

[3]CurrentPatentAssignee:PFIZERINC;MIRATILTREATSTOCK;MIRATITHERAPEUTICS,INC.-WO2021/41671,2021,A1

[4]CurrentPatentAssignee:PFIZERINC;MIRATITHERAPEUTICS,INC.-WO2022/31678,2022,A1

628691-93-0

2-chloro-3-fluoro-5-iodo-4-aminopyridine

[1]Patent:WO2017/12647,2017,A1

1227577-03-8

2-chloro-3-fluoro-5-iodo-4-aminopyridine

[1]Patent:WO2017/12647,2017,A1.Locationinpatent:Paragraph0503

97-94-9

1801841-62-2

2071268-93-2

[1]CurrentPatentAssignee:GALAPAGOSNV-WO2017/12647,2017,A1Locationinpatent:Paragraph0504

64-17-5

CASUnavailable

1801841-62-2

2454397-74-9

[1]CurrentPatentAssignee:TAILIBIOTECHNOLOGYSHANGHAI;TYLIGANDBIOSCIENCESHANGHAI-WO2022/95960,2022,A1Locationinpatent:Page/Pagecolumn44

[2]CurrentPatentAssignee:SHANGHAIPHARMACEUTICALSHOLDINGCOMPANYLIMITED-WO2022/68921,2022,A1Locationinpatent:Page/Pagecolumn485-487

[3]CurrentPatentAssignee:PFIZERINC-WO2020/146613,2020,A1Locationinpatent:Paragraph0319-0320

[4]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/42630,2022,A1Locationinpatent:Paragraph417

[5]CurrentPatentAssignee:ALLISTPHARMACEUTICALSINC-WO2022/161489,2022,A1Locationinpatent:Page/Pagecolumn110;112

[6]CurrentPatentAssignee:UMBRATHERAPEUTICS-WO2022/187688,2022,A1Locationinpatent:Page/Pagecolumn236;232

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS